96802 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses; RNA viruses; Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
Sub-classes:LENTIVIRAL-BASED VECTORS AND RELATED SYSTEMS AND METHODS FOR EUKARYOTIC GENE EDITING
#2COMPOSITIONS AND METHODS FOR THE PRODUCTION OF LIBRARIES
#3LIPID PARTICLES CONTAINING A TRUNCATED BABOON ENDOGENOUS RETROVIRUS (BaEV) ENVELOPE GLYCOPROTEIN AND RELATED METHODS AND USES
#4COMPOSITIONS AND METHODS FOR ENHANCED LENTIVIRAL PRODUCTION
#5INTERMEDIATE FILAMENT-DERIVED PEPTIDES AND THEIR USES
#6Protein-based purification matrices and methods of using the same
#7LENTIVIRAL-BASED VECTORS AND RELATED SYSTEMS AND METHODS FOR EUKARYOTIC GENE EDITING
#8Artificial Target Cells for in-vitro CAR Cytotoxicity and ADCC validation
#9METHODS AND COMPOSITIONS FOR TRANSDUCING AND EXPANDING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF
#10SELECTIVE CD8-POSITIVE T CELL-INDUCING VACCINE ANTIGEN
#11Lentiviral protein delivery system for RNA-guided genome editing
#12Compositions comprising CH848 envelopes and uses thereof
#13Vaccine and therapeutic delivery system
#14Immunogenic compositions comprising FIV and HIV gag antigens
#15Vaccine and therapeutic delivery system
#16MATERIALS AND METHODS FOR DETECTING, PREVENTING, AND TREATING RETROVIRAL INFECTION
#17Anti-HIV peptides and methods of use thereof
#18Process for the production of biologically active HIV-1 tat protein
#19Method for inducing cross-reactive immune responses to the human immunodeficiency virus (HIV) in a host by administering feline immunodeficiency virus (FIV) capsid (CA) or reverse transcriptase (RT) immunogens